1. Home
  2. GNPX vs ARTW Comparison

GNPX vs ARTW Comparison

Compare GNPX & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • ARTW
  • Stock Information
  • Founded
  • GNPX 2009
  • ARTW 1956
  • Country
  • GNPX United States
  • ARTW United States
  • Employees
  • GNPX N/A
  • ARTW N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • GNPX Health Care
  • ARTW Industrials
  • Exchange
  • GNPX Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • GNPX 10.8M
  • ARTW 11.9M
  • IPO Year
  • GNPX 2018
  • ARTW N/A
  • Fundamental
  • Price
  • GNPX $2.97
  • ARTW $2.38
  • Analyst Decision
  • GNPX
  • ARTW
  • Analyst Count
  • GNPX 0
  • ARTW 0
  • Target Price
  • GNPX N/A
  • ARTW N/A
  • AVG Volume (30 Days)
  • GNPX 299.4K
  • ARTW 44.7K
  • Earning Date
  • GNPX 11-14-2025
  • ARTW 10-07-2025
  • Dividend Yield
  • GNPX N/A
  • ARTW N/A
  • EPS Growth
  • GNPX N/A
  • ARTW N/A
  • EPS
  • GNPX N/A
  • ARTW 0.49
  • Revenue
  • GNPX N/A
  • ARTW $24,079,949.00
  • Revenue This Year
  • GNPX N/A
  • ARTW N/A
  • Revenue Next Year
  • GNPX N/A
  • ARTW N/A
  • P/E Ratio
  • GNPX N/A
  • ARTW $5.99
  • Revenue Growth
  • GNPX N/A
  • ARTW N/A
  • 52 Week Low
  • GNPX $2.77
  • ARTW $1.43
  • 52 Week High
  • GNPX $63.00
  • ARTW $4.71
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 42.93
  • ARTW 49.96
  • Support Level
  • GNPX $2.77
  • ARTW $2.25
  • Resistance Level
  • GNPX $5.00
  • ARTW $2.41
  • Average True Range (ATR)
  • GNPX 0.48
  • ARTW 0.13
  • MACD
  • GNPX -0.27
  • ARTW 0.03
  • Stochastic Oscillator
  • GNPX 8.07
  • ARTW 77.22

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: